New USPTO rules confirm that AI can support the invention process, but only humans can legally claim inventorship under U.S.

The U.S. patent validates a biological approach to degrading glyphosate as pressure grows around herbicide safety and ...

Handouts are not uncommon at industry events. But at Mutinex’s Marketers & Money, attendees might have been surprised when an ...

When UC Berkeley biochemist Jennifer Doudna first began studying how bacteria fight virus infections, she had no idea it ...

If you are looking to own a stock for the long term, these out-of-favor drugmakers have proven they have what it takes to ...

On this episode of Understanding IP Matters, Allison Gaul discusses the aggressive landscape of data acquisition by various AI entities.

Amgen Inc. is at least fairly valued, with improving balance sheet metrics and a robust growth pipeline offsetting looming ...

Mastick was six months pregnant when she got scheduled to appear on the show—in the nick of time before she was too far along ...

The FDA’s effort to curb high drug costs by accelerating approvals of cheaper medicines similar to expensive biologics will ...

A new Apple study presents a method that lets an AI model learn one aspect of the structure of brain electrical activity ...

USPTO Director John Squires has taken steps making it likelier for AI and software-related inventions to overcome § 101 patent eligibility rejections. The newly precedential Ex parte Desjardins ...